Cytotoxic chemotherapy is a component of treatment for around a third of primary breast cancers, comprising those associated with relatively poor prognoses such as larger, lymph node positive, HER2-positive, or triple-negative tumours [1]. Here, ERBB2 is linked to breast cancer.